loader
Please Wait
Applying Filters...

Approved Drug Products containing (alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate listed with Health Canada. Original Data : Health Canada Website

Menu
$ API Ref.Price (USD/KG) : 361Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2AA PHARMA INC

02 3APOTEX INC

03 3AURO PHARMA INC

04 2Pharmascience Inc.

05 5SANDOZ CANADA INCORPORATED

06 2TEVA CANADA LIMITED

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA

Brand Name : AA-LEVOCARB CR

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 50MG

Packaging : 100

Approval Date :

Application Number : 2245211

Regulatory Info : Prescription

Registration Country : Canada

blank

02

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA

Brand Name : APO-LEVOCARB - TAB 10MG/100MG

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100

Approval Date :

Application Number : 2195933

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA

Brand Name : APO-LEVOCARB - TAB 25MG/250MG

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 100/500

Approval Date :

Application Number : 2195968

Regulatory Info : Prescription

Registration Country : Canada

blank

04

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA

Brand Name : APO-LEVOCARB-TAB 25MG/100MG

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 100/500

Approval Date :

Application Number : 2195941

Regulatory Info : Prescription

Registration Country : Canada

blank

05

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Carbidopa

Brand Name : PMS-LEVOCARB CR

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 25MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

blank

06

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Carbidopa

Brand Name : PMS-LEVOCARB CR

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 50MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

blank

07

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA

Brand Name : STALEVO

Dosage Form : TABLET

Dosage Strength : 18.75MG

Packaging :

Approval Date :

Application Number : 2337827

Regulatory Info : Prescription

Registration Country : Canada

blank

08

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA

Brand Name : STALEVO

Dosage Form : TABLET

Dosage Strength : 31.25MG

Packaging :

Approval Date :

Application Number : 2337835

Regulatory Info : Prescription

Registration Country : Canada

blank

09

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA

Brand Name : TEVA-LEVOCARBIDOPA

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 100/500

Approval Date :

Application Number : 2244495

Regulatory Info : Prescription

Registration Country : Canada

blank

10

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

CARBIDOPA

Brand Name : TEVA-LEVOCARBIDOPA

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 100/500

Approval Date :

Application Number : 2244496

Regulatory Info : Prescription

Registration Country : Canada

blank